Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Management of optic-hypothalamic gliomas in children: still a challenging problem.

Management of optic-hypothalamic gliomas in children: still a challenging problem. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Management of optic-hypothalamic gliomas in children: still a challenging problem. Abstract Text:

    luca massimiLuca Massimi,tommaso tufoTommaso Tufo,concezio di roccoConcezio Di Rocco,luca massimiLuca Massimi,tommaso tufoTommaso Tufo,concezio di roccoConcezio Di Rocco,

    Optic pathway-hypothalamic gliomas (OPHGs) are rare, often unresectable tumors that mostly occur in childhood. Their biological behavior is unpredictable, although they tend to follow an aggressive clinical course in infants and a benign course in children with neurofibromatosis type 1. Optimal management is still controversial. Nonprogressing OPHGs are usually followed by surveillance alone. Surgery is advocated for progressing tumors to decompress the optic pathways, obtain a quick relief from intracranial hypertension and allow histologic examination (when needed). The current trend is in favor of conservative surgical behavior, except for resectable tumors. Chemotherapy is increasingly used in the management of OPHGs, especially in infants, to delay radiotherapy. Carboplatin and vincristine are the most frequently used drugs, although several chemotherapeutic agents in different combinations are currently employed with good results. Radiotherapy is utilized in children over 5 years of age as an adjuvant or as an alternative to surgery. The prognosis of OPHGs is quite good, with regard to the overall survival rate (70-100% at 5 years), but less favorable in terms of late morbidity.

    Management of optic-hypothalamic gliomas in children: still a challenging problem. Publishing Authors By Initials

    l massimiL Massimi,t tufoT Tufo,c di roccoC Di Rocco,l massimiL Massimi,t tufoT Tufo,c di roccoC Di Rocco,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Management of optic-hypothalamic gliomas in children: still a challenging problem. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Expert review of anticancer therapy

    VOLUME: 7

    Page Numbers: 1591-610

    Journal Abbreviation: Expert Rev Anticancer Ther

    ISSN: 1744-8328

    DAY: 20

    MONTH: Nov

    YEAR: 2007

    Management of optic-hypothalamic gliomas in children: still a challenging problem. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101123358

    Management of optic-hypothalamic gliomas in children: still a challenging problem. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Management of optic-hypothalamic gliomas in children: still a challenging problem. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Management of optic-hypothalamic gliomas in children: still a challenging problem.

    AFFILIATION: Catholic University Medical School, Pediatric Neurosurgery, Institute of Neurosurgery, Largo A Gemelli 8, 00168, Rome, Italy. lmassimi@email.it

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Expert Rev Anticancer Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Management of optic-hypothalamic gliomas in children: still a challenging problem Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News